We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Trocar Injuries on the Increase

By HospiMedica staff writers
Posted on 27 Jul 2005
A study has shown that in the period from 1997 to mid-2002, the U.S. More...
Food and Drug Administration (FDA, Washington, DC, USA) received more than 1,300 laparoscopic trocar injury reports, including reports of 30 or more deaths since then. The study was updated in June 2005 after originally being completed in November 2003.

"In order to perform a laparoscopic procedure, typically from 2-4 trocars, or access ports, are inserted into the abdominal cavity to allow entry of the required laparoscopic instruments. Insertion of these trocars carries a risk for life-threatening injury,” said FDA officials. "Hemorrhage due to vessel injury and infection secondary to bowel injury, especially when diagnosis is delayed, are the most serious complications and the most likely to result in death.

Most data suggest that the rate of trocar-related complications is less than 3%, according to the FDA investigators. Patient records in military facilities showed a 6% complication rate, while the average incidence of trocar-related vascular injuries is only about 0.1%. Bowel injuries occur more frequently, showing an average incidence of less than 1%. Overall, mortality rates were reported to be 0.1% or less.

"Injuries appear to occur most frequently during insertion of trocars into the abdomen or pelvis. Several studies suggest that the initial trocar insertion is the most dangerous aspect of trocar use, and possibly the most dangerous step in minimally invasive surgery,” according to FDA sources. A 1996 study found that 83% of vascular injuries, 75% of bowel injuries, and 50% of local hemorrhage injuries were caused during primary trocar insertion.

Other reported findings of the study were that major vessel injuries are usually the result of operator error, and that delayed awareness of injury in people over the age of 59 showed a significant association with a fatal outcome.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.